FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2124990868> ?p ?o ?g. }

• W2124990868 endingPage "3512" @default.
• W2124990868 startingPage "3503" @default.
• W2124990868 abstract "Objective: Opioid therapy is frequently associated with treatment-limiting constipation. Naloxone is an opioid antagonist with low oral systemic bioavailability. This Phase III clinical trial assessed the safety and efficacy of an oral fixed-ratio combination of oxycodone prolonged-release (PR) and naloxone PR compared with oxycodone PR in relieving opioid-induced constipation.Study design: This double-blind, multicenter trial was conducted in specialist and primary care centers in four European countries in an out-patients setting. The study included 322 adult patients with moderate-to-severe, noncancer pain requiring opioid therapy in a range of ≥20 mg/day and ≤50 mg/day oxycodone. Following a run-in phase patients were randomized to receive oxycodone PR/naloxone PR or oxycodone PR for 12 weeks. The primary outcome was improvement in constipation as measured using the Bowel Function Index (BFI). Secondary/exploratory assessments focused on pain intensity and additional bowel parameters.Trial registration: NCT00412152.Results: A significant improvement in BFI scores occurred with oxycodone PR/naloxone PR compared with oxycodone PR after 4 weeks of double-blind treatment (−26.9 vs. −9.4, respectively; p < 0.0001), observed after only 1 week of treatment and continued until study end. A significant increase in the number of complete spontaneous bowel movements and decrease in laxative use were also reported. This improvement in bowel function was achieved without compromising the analgesic efficacy of the oxycodone component; pain intensity remained constant throughout the study. The incidence of adverse events was comparable in both groups and consistent with those expected of opioid analgesics. As the study was limited to a dose range of up to 50 mg oxycodone equivalent per day, further research on higher doses would be recommended.Conclusion: The fixed-ratio combination of oxycodone PR/naloxone PR is superior to oxycodone PR alone, offering patients effective analgesia while significantly improving opioid-induced constipation." @default.
• W2124990868 created "2016-06-24" @default.
• W2124990868 creator A5008880258 @default.
• W2124990868 creator A5011461869 @default.
• W2124990868 creator A5012190179 @default.
• W2124990868 creator A5030026468 @default.
• W2124990868 creator A5040148558 @default.
• W2124990868 creator A5043735484 @default.
• W2124990868 creator A5047168727 @default.
• W2124990868 creator A5048886165 @default.
• W2124990868 creator A5055499310 @default.
• W2124990868 creator A5078037235 @default.
• W2124990868 creator A5086106244 @default.
• W2124990868 creator A5087382572 @default.
• W2124990868 date "2008-11-12" @default.
• W2124990868 modified "2023-10-18" @default.
• W2124990868 title "Fixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain" @default.
• W2124990868 cites W106147234 @default.
• W2124990868 cites W1979282061 @default.
• W2124990868 cites W1979844313 @default.
• W2124990868 cites W1987078656 @default.
• W2124990868 cites W1990538516 @default.
• W2124990868 cites W2040832386 @default.
• W2124990868 cites W2052807712 @default.
• W2124990868 cites W2060855217 @default.
• W2124990868 cites W2071858540 @default.
• W2124990868 cites W2113250961 @default.
• W2124990868 cites W2118983431 @default.
• W2124990868 cites W2129860136 @default.
• W2124990868 cites W2132469876 @default.
• W2124990868 cites W2134441221 @default.
• W2124990868 cites W2145469804 @default.
• W2124990868 cites W2164341191 @default.
• W2124990868 cites W2188872902 @default.
• W2124990868 cites W3137938605 @default.
• W2124990868 cites W4211164730 @default.
• W2124990868 doi "https://doi.org/10.1185/03007990802584454" @default.
• W2124990868 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19032132" @default.
• W2124990868 hasPublicationYear "2008" @default.
• W2124990868 type Work @default.
• W2124990868 sameAs 2124990868 @default.
• W2124990868 citedByCount "170" @default.
• W2124990868 countsByYear W21249908682012 @default.
• W2124990868 countsByYear W21249908682013 @default.
• W2124990868 countsByYear W21249908682014 @default.
• W2124990868 countsByYear W21249908682015 @default.
• W2124990868 countsByYear W21249908682016 @default.
• W2124990868 countsByYear W21249908682017 @default.
• W2124990868 countsByYear W21249908682018 @default.
• W2124990868 countsByYear W21249908682019 @default.
• W2124990868 countsByYear W21249908682020 @default.
• W2124990868 countsByYear W21249908682022 @default.
• W2124990868 countsByYear W21249908682023 @default.
• W2124990868 crossrefType "journal-article" @default.
• W2124990868 hasAuthorship W2124990868A5008880258 @default.
• W2124990868 hasAuthorship W2124990868A5011461869 @default.
• W2124990868 hasAuthorship W2124990868A5012190179 @default.
• W2124990868 hasAuthorship W2124990868A5030026468 @default.
• W2124990868 hasAuthorship W2124990868A5040148558 @default.
• W2124990868 hasAuthorship W2124990868A5043735484 @default.
• W2124990868 hasAuthorship W2124990868A5047168727 @default.
• W2124990868 hasAuthorship W2124990868A5048886165 @default.
• W2124990868 hasAuthorship W2124990868A5055499310 @default.
• W2124990868 hasAuthorship W2124990868A5078037235 @default.
• W2124990868 hasAuthorship W2124990868A5086106244 @default.
• W2124990868 hasAuthorship W2124990868A5087382572 @default.
• W2124990868 hasConcept C126322002 @default.
• W2124990868 hasConcept C170493617 @default.
• W2124990868 hasConcept C197934379 @default.
• W2124990868 hasConcept C2776029756 @default.
• W2124990868 hasConcept C2778750930 @default.
• W2124990868 hasConcept C2781063702 @default.
• W2124990868 hasConcept C2781112942 @default.
• W2124990868 hasConcept C42219234 @default.
• W2124990868 hasConcept C71924100 @default.
• W2124990868 hasConceptScore W2124990868C126322002 @default.
• W2124990868 hasConceptScore W2124990868C170493617 @default.
• W2124990868 hasConceptScore W2124990868C197934379 @default.
• W2124990868 hasConceptScore W2124990868C2776029756 @default.
• W2124990868 hasConceptScore W2124990868C2778750930 @default.
• W2124990868 hasConceptScore W2124990868C2781063702 @default.
• W2124990868 hasConceptScore W2124990868C2781112942 @default.
• W2124990868 hasConceptScore W2124990868C42219234 @default.
• W2124990868 hasConceptScore W2124990868C71924100 @default.
• W2124990868 hasIssue "12" @default.
• W2124990868 hasLocation W21249908681 @default.
• W2124990868 hasLocation W21249908682 @default.
• W2124990868 hasOpenAccess W2124990868 @default.
• W2124990868 hasPrimaryLocation W21249908681 @default.
• W2124990868 hasRelatedWork W1607390008 @default.
• W2124990868 hasRelatedWork W1878051874 @default.
• W2124990868 hasRelatedWork W1964841359 @default.
• W2124990868 hasRelatedWork W2037722870 @default.
• W2124990868 hasRelatedWork W2090537340 @default.
• W2124990868 hasRelatedWork W2362169642 @default.
• W2124990868 hasRelatedWork W2550361575 @default.
• W2124990868 hasRelatedWork W2559750204 @default.
• W2124990868 hasRelatedWork W2598165083 @default.

• next